Literature DB >> 22717328

Medial temporal lobe atrophy relates to executive dysfunction in Alzheimer's disease.

Joukje M Oosterman1, Saskia Oosterveld, Marcel G Olde Rikkert, Jurgen A Claassen, Roy P C Kessels.   

Abstract

BACKGROUND: White matter hyperintensities (WMH) have frequently been associated with lower executive function performance. Little is known, however, about the effects of hippocampal atrophy on executive control in Alzheimer's disease (AD). The present study focused on the association of hippocampal atrophy with executive function in AD patients and examined whether a threshold effect is present, indicating that a certain amount of brain damage must be present before cognitive function becomes impaired. Finally, we examined the combined effect of hippocampal atrophy and WMH on cognitive task performance.
METHODS: We retrospectively collected neuropsychological and neuroimaging data of 94 AD patients. These patients completed tasks of general cognitive function, executive function, memory, and processing speed. With magnetic resonance imaging (MRI), hippocampal atrophy was rated as medial temporal lobe atrophy (MTA) and cerebrovascular disease was rated as WMH using validated visual rating scales.
RESULTS: Medial temporal lobe atrophy (MTA) was associated with lower executive function, general cognitive function, and episodic memory performance. A threshold effect was present, indicating that severe to very severe, but not moderate, MTA was associated with lower executive function. WMH were significantly associated with a single executive test only, whereas the interaction between WMH and MTA was not significantly related to any of the cognitive tasks.
CONCLUSIONS: Our findings suggest that AD neuropathology in itself may be responsible for executive dysfunction. Potential explanations for these findings are discussed, focusing on the role of the hippocampus in executive function tests and reduced frontal-posterior connectivity in this patient sample.

Entities:  

Mesh:

Year:  2012        PMID: 22717328     DOI: 10.1017/S1041610212000506

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  7 in total

1.  Decreased γ-aminobutyric acid levels in the parietal region of patients with Alzheimer's disease.

Authors:  Xue Bai; Richard A E Edden; Fei Gao; Guangbin Wang; Lebin Wu; Bin Zhao; Minzhong Wang; Queenie Chan; Weibo Chen; Peter B Barker
Journal:  J Magn Reson Imaging       Date:  2014-05-27       Impact factor: 4.813

2.  Posterior Atrophy and Medial Temporal Atrophy Scores Are Associated with Different Symptoms in Patients with Alzheimer's Disease and Mild Cognitive Impairment.

Authors:  Jung-Lung Hsu; Wei-Ju Lee; Yi-Chu Liao; Jiing-Feng Lirng; Shuu-Jiun Wang; Jong-Ling Fuh
Journal:  PLoS One       Date:  2015-09-15       Impact factor: 3.240

3.  Cognitive impairments associated with medial temporal atrophy and white matter hyperintensities: an MRI study in memory clinic patients.

Authors:  Eduard J Overdorp; Roy P C Kessels; Jurgen A Claassen; Joukje M Oosterman
Journal:  Front Aging Neurosci       Date:  2014-05-27       Impact factor: 5.750

4.  Medial temporal lobe atrophy, white matter hyperintensities and cognitive impairment among Nigerian African stroke survivors.

Authors:  Rufus O Akinyemi; Michael Firbank; Godwin I Ogbole; Louise M Allan; Mayowa O Owolabi; Joshua O Akinyemi; Bolutife P Yusuf; Oluremi Ogunseyinde; Adesola Ogunniyi; Raj N Kalaria
Journal:  BMC Res Notes       Date:  2015-10-30

5.  Body mass index related to executive function and hippocampal subregion volume in subjective cognitive decline.

Authors:  Ruilin Chen; Guiyan Cai; Shurui Xu; Qianqian Sun; Jia Luo; Yajun Wang; Ming Li; Hui Lin; Jiao Liu
Journal:  Front Aging Neurosci       Date:  2022-08-17       Impact factor: 5.702

6.  Treating Alzheimer's disease with Yizhijiannao granules by regulating expression of multiple proteins in temporal lobe.

Authors:  Hong Zhu; Liuyang Luo; Sihang Hu; Keli Dong; Guangcheng Li; Ting Zhang
Journal:  Neural Regen Res       Date:  2014-07-01       Impact factor: 5.135

Review 7.  Alzheimer's disease: Unique markers for diagnosis & new treatment modalities.

Authors:  Neelum T Aggarwal; Raj C Shah; David A Bennett
Journal:  Indian J Med Res       Date:  2015-10       Impact factor: 2.375

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.